Sage Therapeutics shares were up after the company won approval for the postpartum depression treatment Zulresso (brexanalone).

Socially isolated people may be more likely to develop diabetes than adults with closer ties to family and friends, a recent study suggests.

Science needs champions. That is the belief of Johnson & Johnson’s Seema Kumar, vice president of Innovation, Global Health and Science Policy Communication. And that is a belief being harnessed by a new J&J initiative that celebrates the legacy of Dr. Paul Janssen, one of the most prolific scientific innovators of the past century.

Teva Pharmaceutical Industries Ltd. announced that the U.S. FDA approved Austedo (deutetrabenazine) tablets for the treatment of tardive dyskinesia in adults.

Spending on prescription medicines in the United States will increase 4-7 percent through 2021, reaching $580 billion to $610 billion, according to a report released by QuintilesIMS Holdings.

The U.S. Senate voted overwhelmingly to support sweeping legislation that will reshape the way the Food and Drug Administration approves new medicines.

The House of Reps is expected to pass a $6.3 billion piece of legislation designed to spur medical innovation, speed access to new drugs, expand mental health treatment, and combat opioid abuse.

Med Ad News’ first edition of the Pharma Leaders of Innovation special feature showcases two CEOs focusing outside the big pharma box and an agency tech leader.

Even during a humanitarian crisis, treating mental illnesses is not an optional luxury, experts said before a World Bank/World Health Organization meeting on the issue in Washington.

(Reuters Health) – Even though teens get more exercise at school than anywhere else, it still isn’t enough to meet minimum daily activity levels recommended for good physical and mental health, a U.S. study suggests. Children and teens should get at least 60 minutes of moderate to vigorous activity every day, the World Health Organization […]